PATENT CLAIM ANALYSIS

Application Number: 15969383
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "273700"]

Abstract:
The present invention relates to a process for the preparation of anhydrous crystalline 2-(R)-[(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl]-1H-benzimidazole (dexlansoprazole).

Claim (Index 13):
The process according to  claim 1 , wherein the dispersing of dexlansoprazole in the solvent is carried out at a temperature of up to about 40\u00b0 C.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12830713', '15501908', '12693539', '12356004', '12283702']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826648339618193
- 35 USC 102 Novelty (BERT): 0.5599539105765858
- Combined Prediction Score: 0.760393741623296
- Mean Citation Score: 264.91933400000005
- Max Citation Score: 486.37616
- Similarity Product: 314.29488366164213

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test